Synthesis of C-20 substituted mutilin

ORGN 166

Masanori Takadoi, masanori.takadoi@mb.kyorin-pharm.co.jp, Taro Sato, and Yasumichi Fukuda. Kyorin Pharmaceutical Co., Ltd, Discovery Research Laboratories, 2399-1 Nogi, Nogi-machi, Shimotsuga-gun, Tochigi, 329-0114, Japan
Pleuromutilin, isolated from Pleurotus species, is a representative diterpene mutilin antibiotic. The antibacterial activity level of pleuromutilin against methicillin-resistant Staphylococcus aureus (MRSA) is as high as that of vancomycin. In the present study, as part of an ongoing effort to develop a novel mutilin antibiotic, we focused on the synthesis of C-20 modified analogues. Stereoselective alkylation at the C-12 position of de-ethenylated mutilin was found to be a key methodology for the synthesis of C-20 substituted mutilins. Indeed, C-12 alkylated mutilins were successfully converted to the C-20 substituted mutilins bearing a fluoro, methyl, or trifluoromethyl group at the C-20 position by way of dehydrosulfenylation, alkyne isomerization, or trifluoromethylation.